Table 10.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1992 to 2001

Recipients with Intestine Transplants

		Year of Transplant
		1992	1993	1994	1995	1996	1997	1998	1999	2000	2001
Transplants		22	34	23	46	45	68	70	73	79	111
Tx With Follow-up Immunosuppression Info		0	6	14	28	28	35	41	42	55	79
Corticosteroids	Category Usage	0.0%	100.0%	92.9%	92.9%	100.0%	94.3%	97.6%	100.0%	100.0%	86.1%
	Steroids	0.0%	100.0%	92.9%	92.9%	100.0%	94.3%	97.6%	100.0%	100.0%	86.1%
Cyclosporine	Category Usage	0.0%	33.3%	21.4%	14.3%	10.7%	5.7%	2.4%	2.4%	0.0%	0.0%
	Cyclosporin	0.0%	33.3%	21.4%	7.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	2.4%	0.0%	0.0%
	Neoral	0.0%	0.0%	0.0%	7.1%	10.7%	5.7%	2.4%	0.0%	0.0%	0.0%
Tacrolimus	Category Usage	0.0%	83.3%	85.7%	92.9%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%
	FK506	0.0%	83.3%	85.7%	92.9%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%
Antimetabolites	Category Usage	0.0%	33.3%	14.3%	42.9%	67.9%	34.3%	34.1%	35.7%	16.4%	13.9%
	Azathioprine	0.0%	33.3%	14.3%	28.6%	25.0%	17.1%	4.9%	16.7%	0.0%	11.4%
	Mycophenolate mofetil	0.0%	0.0%	0.0%	28.6%	57.1%	22.9%	29.3%	26.2%	16.4%	2.5%
Other	Category Usage	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	23.8%	70.9%	24.1%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	23.8%	70.9%	24.1%
	Cytoxan	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Source: OPTN/SRTR Data as of August 1, 2003.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.